Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 108901-108950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT02956798
SAbR For Oligometastatic Renal Cell Carcinoma
PHASE2Active, not recruiting
23 participants
Started: Jul 19, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03560882
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
PHASE1Active, not recruiting
50 participants
Started: Jul 19, 2018 · Completed: Aug 1, 2025
6 conditions1 sponsor1 location
NCT03559114
PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
PHASE3Recruiting
1,100 participants
Started: Jul 19, 2018 · Completed: Dec 31, 2027
1 condition2 sponsors12 locations
NCT03288532
Renal Adjuvant MultiPle Arm Randomised Trial
PHASE3Recruiting
1,750 participants
Started: Jul 19, 2018 · Completed: Dec 1, 2034
1 condition4 sponsors35 locations
NCT03582124
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
PHASE1/PHASE2Recruiting
30 participants
Started: Jul 19, 2018 · Completed: Feb 28, 2027
5 conditions1 sponsor1 location
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
PHASE2/PHASE3Recruiting
1,541 participants
Started: Jul 19, 2018 · Completed: Nov 30, 2036
1 condition1 sponsor182 locations
NCT04020783
Primary Aldosteronism: Prospective Screening Registry in China
N/ARecruiting
10,000 participants
Started: Jul 18, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03519945
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
PHASE3Active, not recruiting
1,063 participants
Started: Jul 18, 2018 · Completed: Dec 31, 2027
1 condition1 sponsor361 locations
NCT03547856
"A Registry Study on the Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"
N/ARecruiting
10,000 participants
Started: Jul 18, 2018 · Completed: Dec 30, 2026
3 conditions1 sponsor1 location
NCT03617562
Superior Capsular Reconstruction vs. Partial Repair for Massive Rotator Cuff Tears
NARecruiting
70 participants
Started: Jul 18, 2018 · Completed: Jul 31, 2028
1 condition4 sponsors2 locations
NCT03772548
CNS Changes Following SCI
N/ARecruiting
450 participants
Started: Jul 18, 2018 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT03933670
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients with Prostate Cancer on Active Surveillance
PHASE2Recruiting
60 participants
Started: Jul 18, 2018 · Completed: Oct 31, 2026
2 conditions3 sponsors1 location
NCT03503799
Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer
N/AActive, not recruiting
1,191 participants
Started: Jul 17, 2018 · Completed: Oct 1, 2032
3 conditions2 sponsors40 locations
NCT03585621
Stereotactic Body Radiation Therapy for Breast Cancer
NAActive, not recruiting
24 participants
Started: Jul 17, 2018 · Completed: Jul 17, 2026
1 condition1 sponsor1 location
NCT03463408
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
EARLY_PHASE1Active, not recruiting
14 participants
Started: Jul 17, 2018 · Completed: Aug 1, 2026
1 condition1 sponsor1 location
NCT03283605
Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas
PHASE1/PHASE2Active, not recruiting
45 participants
Started: Jul 17, 2018 · Completed: Dec 31, 2024
2 conditions2 sponsors3 locations
NCT03592472
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
PHASE3Recruiting
413 participants
Started: Jul 17, 2018 · Completed: Jun 30, 2028
1 condition1 sponsor38 locations
NCT03506893
Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients
NARecruiting
90 participants
Started: Jul 17, 2018 · Completed: May 31, 2027
3 conditions1 sponsor10 locations
NCT03651505
X-linked Hypophosphatemia Disease Monitoring Program
N/AActive, not recruiting
782 participants
Started: Jul 16, 2018 · Completed: Dec 31, 2032
2 conditions2 sponsors38 locations
NCT03228537
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
PHASE1Active, not recruiting
28 participants
Started: Jul 16, 2018 · Completed: Sep 18, 2026
7 conditions1 sponsor177 locations
NCT03623074
Control of Myopia Using Novel Spectacle Lens Designs
NAActive, not recruiting
266 participants
Started: Jul 16, 2018 · Completed: Mar 31, 2026
1 condition1 sponsor14 locations
NCT03598894
Hypertension Chronobiome
N/ARecruiting
150 participants
Started: Jul 16, 2018 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT03612726
The Overall Survival of Patients With Unresectable HCC in Real-life
N/ARecruiting
5,000 participants
Started: Jul 16, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors3 locations
NCT04236791
The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up
NAActive, not recruiting
1,246 participants
Started: Jul 16, 2018 · Completed: Aug 31, 2026
1 condition8 sponsors5 locations
NCT03472664
Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
NARecruiting
120 participants
Started: Jul 16, 2018 · Completed: Apr 30, 2026
2 conditions2 sponsors1 location
NCT03439228
To Brace or Not to Brace for Single Level Lumbar Fusion Pilot
NARecruiting
50 participants
Started: Jul 16, 2018 · Completed: Dec 31, 2025
2 conditions4 sponsors1 location
NCT03607552
Non-contrast DWI for Supplemental Screening
N/AActive, not recruiting
269 participants
Started: Jul 16, 2018 · Completed: Jul 31, 2029
1 condition2 sponsors2 locations
NCT03643276
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
PHASE3Recruiting
5,000 participants
Started: Jul 15, 2018 · Completed: Jul 14, 2028
1 condition2 sponsors115 locations
NCT03606083
Registry in Patients With Aorto-iliac or Iliac Aneurysms
N/AActive, not recruiting
298 participants
Started: Jul 15, 2018 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT03840083
Sleep-dependent Learning in Aging
NARecruiting
584 participants
Started: Jul 15, 2018 · Completed: Jul 15, 2025
1 condition1 sponsor1 location
NCT04088682
Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
N/ARecruiting
200,000 participants
Started: Jul 15, 2018 · Completed: Dec 31, 2035
1 condition1 sponsor1 location
NCT03607565
A New Parameter Derived From DSA to Evaluate Cerebral Perfusion
N/ARecruiting
30,000 participants
Started: Jul 15, 2018 · Completed: Jul 15, 2038
1 condition1 sponsor1 location
NCT03506282
Does Listening to Music Alter the Running Mechanics?
NARecruiting
40 participants
Started: Jul 15, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05774860
Neural Bases of Social Cognitive Processing in Healthy Individuals
N/ARecruiting
200 participants
Started: Jul 14, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03619083
Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer
N/AActive, not recruiting
187 participants
Started: Jul 13, 2018 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT03555851
Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
N/ARecruiting
120 participants
Started: Jul 13, 2018 · Completed: Aug 31, 2035
2 conditions2 sponsors1 location
NCT03178149
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
PHASE1Recruiting
42 participants
Started: Jul 13, 2018 · Completed: Jun 30, 2026
1 condition1 sponsor18 locations
NCT03595059
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
PHASE1Active, not recruiting
169 participants
Started: Jul 13, 2018 · Completed: Jun 30, 2025
1 condition1 sponsor40 locations
NCT03573310
A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS
PHASE1Active, not recruiting
114 participants
Started: Jul 13, 2018 · Completed: Dec 31, 2025
4 conditions1 sponsor18 locations
NCT05203302
Novel Coding Strategies for Children With Cochlear Implants
NARecruiting
190 participants
Started: Jul 12, 2018 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT03582774
Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy
PHASE3Active, not recruiting
193 participants
Started: Jul 12, 2018 · Completed: Jul 12, 2027
1 condition2 sponsors2 locations
NCT03553095
Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis
NAActive, not recruiting
92 participants
Started: Jul 12, 2018 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT03822494
CyberKnife Dose Escalation Prostate Cancer Trial
NAActive, not recruiting
100 participants
Started: Jul 12, 2018 · Completed: Jul 12, 2028
3 conditions1 sponsor1 location
NCT03581318
Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
N/ARecruiting
5,000 participants
Started: Jul 12, 2018 · Completed: Apr 1, 2028
1 condition2 sponsors1 location
NCT03599245
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
PHASE3Active, not recruiting
1,500 participants
Started: Jul 12, 2018 · Completed: Sep 23, 2025
1 condition1 sponsor157 locations
NCT03534323
Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
PHASE1/PHASE2Active, not recruiting
67 participants
Started: Jul 12, 2018 · Completed: Jul 1, 2026
2 conditions2 sponsors7 locations
NCT03532399
Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation
N/ARecruiting
30 participants
Started: Jul 12, 2018 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT03526679
Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Jul 12, 2018 · Completed: Dec 30, 2024
4 conditions2 sponsors2 locations
NCT03820778
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
NAActive, not recruiting
10 participants
Started: Jul 12, 2018 · Completed: Aug 1, 2022
6 conditions1 sponsor1 location
NCT03457675
Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a)
NAActive, not recruiting
2 participants
Started: Jul 11, 2018 · Completed: Jun 30, 2026
1 condition6 sponsors3 locations